PL130564B1 - Process for preparing unit pharmaceutical dose containing lyophilized sodium piperacylin - Google Patents

Process for preparing unit pharmaceutical dose containing lyophilized sodium piperacylin Download PDF

Info

Publication number
PL130564B1
PL130564B1 PL1982235509A PL23550982A PL130564B1 PL 130564 B1 PL130564 B1 PL 130564B1 PL 1982235509 A PL1982235509 A PL 1982235509A PL 23550982 A PL23550982 A PL 23550982A PL 130564 B1 PL130564 B1 PL 130564B1
Authority
PL
Poland
Prior art keywords
concentration
water
lyophilized
piperacillin sodium
solution
Prior art date
Application number
PL1982235509A
Other languages
English (en)
Polish (pl)
Other versions
PL235509A1 (enrdf_load_html_response
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22935482&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL130564(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of PL235509A1 publication Critical patent/PL235509A1/xx
Publication of PL130564B1 publication Critical patent/PL130564B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL1982235509A 1981-03-26 1982-03-18 Process for preparing unit pharmaceutical dose containing lyophilized sodium piperacylin PL130564B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24758681A 1981-03-26 1981-03-26

Publications (2)

Publication Number Publication Date
PL235509A1 PL235509A1 (enrdf_load_html_response) 1982-12-20
PL130564B1 true PL130564B1 (en) 1984-08-31

Family

ID=22935482

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1982235509A PL130564B1 (en) 1981-03-26 1982-03-18 Process for preparing unit pharmaceutical dose containing lyophilized sodium piperacylin

Country Status (23)

Country Link
JP (1) JPS57159708A (enrdf_load_html_response)
AT (1) AT395533B (enrdf_load_html_response)
AU (1) AU549784B2 (enrdf_load_html_response)
BE (1) BE892541A (enrdf_load_html_response)
CA (1) CA1209477A (enrdf_load_html_response)
CH (1) CH652306A5 (enrdf_load_html_response)
DE (2) DE3208505A1 (enrdf_load_html_response)
DK (1) DK157976C (enrdf_load_html_response)
ES (1) ES509234A0 (enrdf_load_html_response)
FR (1) FR2502624B1 (enrdf_load_html_response)
GB (1) GB2095551B (enrdf_load_html_response)
GR (1) GR78386B (enrdf_load_html_response)
HK (1) HK39189A (enrdf_load_html_response)
HU (1) HU186489B (enrdf_load_html_response)
IE (1) IE52936B1 (enrdf_load_html_response)
IL (1) IL64924A (enrdf_load_html_response)
IT (1) IT1147916B (enrdf_load_html_response)
LU (1) LU84031A1 (enrdf_load_html_response)
NL (1) NL192664C (enrdf_load_html_response)
NZ (1) NZ199632A (enrdf_load_html_response)
PL (1) PL130564B1 (enrdf_load_html_response)
SE (1) SE453153B (enrdf_load_html_response)
ZA (1) ZA82605B (enrdf_load_html_response)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207661B1 (en) 1999-02-22 2001-03-27 Baxter International Inc. Premixed formulation of piperacillin sodium and tazobactam sodium injection
CA2543242C (en) 2003-10-23 2015-04-14 Otsuka Pharmaceutical Co., Ltd. Controlled release sterile freeze-dried aripiprazole formulation and injectable formulation thereof
ITMI20051630A1 (it) * 2005-09-02 2007-03-03 Acs Dobfar Spa Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi
MY152789A (en) 2007-07-31 2014-11-28 Otsuka Pharma Co Ltd Methods for producing aripiprazole suspension and freeze-dried formulation
CN114200057A (zh) * 2021-12-14 2022-03-18 坛墨质检科技股份有限公司 一种可替代标准溶液的抗生素类药物固体混合标准物质的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2608507A (en) * 1949-08-20 1952-08-26 Sharp & Dohme Inc Dialkyl sulfamyl benzoic acids
CH546783A (de) * 1971-03-11 1974-03-15 Hoffmann La Roche Verfahren zur herstellung von penicilloinsaeurederivate.
JPS5817728B2 (ja) * 1973-11-20 1983-04-09 山之内製薬株式会社 アンピシリンナトリウムエン ノ セイホウ
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
JPS52143221A (en) * 1976-05-22 1977-11-29 Yamanouchi Pharmaceut Co Ltd Novel preparations for rectal administration
DE2623835C2 (de) * 1976-05-28 1978-03-02 C.H. Boehringer Sohn, 6507 Ingelheim Verfahren zur Herstellung von Natriumampicillin
JPS542337A (en) * 1977-06-08 1979-01-09 Toyama Chem Co Ltd Bactericidal composition for medical use
FR2403078A1 (fr) * 1977-09-19 1979-04-13 Lafon Labor Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
JPS54147917A (en) * 1978-05-08 1979-11-19 Sumitomo Chem Co Ltd Ferrze-drying method
PT70225A (en) * 1978-10-03 1979-10-01 Gist Brocades Nv Process for the preparation of sodium amoxicillin preparations
DE2925009A1 (de) * 1979-06-21 1981-01-08 Basf Ag Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung

Also Published As

Publication number Publication date
PL235509A1 (enrdf_load_html_response) 1982-12-20
LU84031A1 (de) 1982-07-08
CH652306A5 (de) 1985-11-15
AU549784B2 (en) 1986-02-13
ATA92982A (de) 1992-06-15
IT1147916B (it) 1986-11-26
HU186489B (en) 1985-08-28
IE52936B1 (en) 1988-04-13
GB2095551B (en) 1984-10-03
FR2502624B1 (fr) 1985-10-25
DK48382A (da) 1982-09-27
SE453153B (sv) 1988-01-18
GR78386B (enrdf_load_html_response) 1984-09-26
NL8201251A (nl) 1982-10-18
ES8302455A1 (es) 1982-12-16
DK157976B (da) 1990-03-12
GB2095551A (en) 1982-10-06
AU7986582A (en) 1982-09-30
CA1209477A (en) 1986-08-12
DE3208505A1 (de) 1982-10-21
ES509234A0 (es) 1982-12-16
DE19375106I2 (de) 2006-02-16
DK157976C (da) 1990-08-27
JPH0219804B2 (enrdf_load_html_response) 1990-05-07
JPS57159708A (en) 1982-10-01
DE3208505C2 (enrdf_load_html_response) 1991-11-28
ZA82605B (en) 1982-12-29
FR2502624A1 (fr) 1982-10-01
NL192664B (nl) 1997-08-01
IT8248034A0 (it) 1982-03-19
HK39189A (en) 1989-05-19
IL64924A0 (en) 1982-04-30
BE892541A (fr) 1982-09-20
SE8200591L (sv) 1982-09-27
AT395533B (de) 1993-01-25
IE820703L (en) 1982-09-26
NZ199632A (en) 1985-07-12
NL192664C (nl) 1997-12-02
IL64924A (en) 1985-07-31

Similar Documents

Publication Publication Date Title
KR100712640B1 (ko) 히스톤 탈아세틸화효소 저해 활성을 갖는 벤즈아미드 제제
BG66329B1 (bg) Лиофилизиран пантопразолов препарат, инжекция с пантопразол и метод за производството им
CN103919722A (zh) 多柔比星脂质体组合药物及其大工业化生产工艺和用途
CA2481370A1 (en) Process for preparing tannate liquid and semi-solid dosage forms
JPS61189230A (ja) エトポシド製剤
CN106963759B (zh) 用于治疗过度增生性疾病、自身免疫性疾病和心脏病的包含3-奎宁环酮衍生物的水溶液
US4477452A (en) Composition of matter comprising a lyophilized preparation of a penicillin derivative
EP1991239A1 (en) Doxorubicin formulations for anti-cancer use
JPS5874608A (ja) アヘン製剤に関して末梢「きつ」抗作用を有する製薬組成物
PL130564B1 (en) Process for preparing unit pharmaceutical dose containing lyophilized sodium piperacylin
US4534977A (en) Composition of matter comprising a low bulk density lyophilized preparation of Sodium Piperacillin
US4963551A (en) Stable lyophilized form of (S)-(+)-bis-4,4'-(1-methyl-1,2-ethanediyl)2,6-piperazinedione and solutions thereof
CN104414977A (zh) 一种注射用青蒿琥酯和l-精氨酸组合物及其制备方法
US5010064A (en) Inclusion complexes of dipyridamole with cyclodextrins
US3634586A (en) Stable aqueous suspensions of ampicillin
CA2448724A1 (en) 2-methyl-thieno-benzodiazepine lyophilized formulation
RU2272623C2 (ru) РАСТВОР ТЕТРАГИДРАТА МОНОНАТРИЕВОЙ СОЛИ N-[O-(п-ПИВАЛОИЛОКСИБЕНЗОЛСУЛЬФОНИЛАМИНО)БЕНЗОИЛ]ГЛИЦИНА И ГОТОВАЯ ЛЕКАРСТВЕННАЯ ФОРМА НА ЕГО ОСНОВЕ
AU2016224583A1 (en) Method for suppressing bitterness of quinoline derivative
US4775533A (en) Reconstitution of dry fill cyclophosphamide
AU615245B2 (en) Aqueous formulations containing a piperidinylcyclopentylheptenoic acid derivative
KR860000512B1 (ko) 페니실린 유도체의 동결 건조물로 된 주사용량 단위물 제조방법
UA127661C2 (uk) Композиції дантролену та способи їх застосування
CN102204890A (zh) 复水性能优良的依替巴肽冻干粉针
EP0139024B1 (en) Injectable compositions of bbm-928a
JPS6330290B2 (enrdf_load_html_response)